A public-private partnership between ARPA-H and VentureWell in support of the ARPANET-H nationwide health innovation network. Website is maintained by VentureWell staff.
We will be joined by Daria Fedyukina, Ph.D., ARPA-H Program Manager, who specializes in translational science and commercialization strategies involving cell and gene therapies, and Stan Wang, M.D., Ph.D., Founder and CEO of Thymmune Therapeutics, which is leading the Thymus Rejuvenation project. The project aims to restore damaged or non-functional thymus tissue. The meeting is […]
Join us for an information session with Ileana Hancu, Ph.D, ARPA-H, and Aldo Badano, Food and Drug Administration (FDA) Center for Devices and Radiological Health (CRDH). ARPA-H and FDA CDRH […]
Spokes: Register today! We are excited to invite you to the first Strategic Problem-solving for Optimal Knowledge-sharing and Enhancing Solutions (SPOKES) Session! These members-only meetings provide an opportunity for spoke-to-spoke […]
Join us for an information session with Ileana Hancu, Ph.D, ARPA-H, and Aldo Badano, Food and Drug Administration (FDA) Center for Devices and Radiological Health (CRDH). ARPA-H and FDA CDRH […]
Kimberley Steele, M.D., Ph.D., ARPA-H Program Manager, will join the Investor Catalyst Hub’s April member meeting to discuss the importance of lymphatics in health. Dr. Steele, an internationally recognized expert in bariatric surgery, the gut-brain axis, and neuroimaging in obesity, will share how personal experience has driven her passion for advancing lymphatic medicine–an area of […]
Join us for our first joint members-only meeting hosted by the Customer Experience Hub and Investor Catalyst Hub. You will gain a comprehensive overview of the ARPANET-H network, its remarkable capabilities, and the many benefits it offers to our valued members.
ARPA-H is looking for performers for the Building Resilient Environments for Air and Total HEalth (BREATHE) program! Join ARPA-H PM Jessica Green, Ph.D., to learn more.
Portal Biotechnologies is excited to be partnering with Bayer Co.Lab for a special cocktail reception with the ARPA-H Investor Catalyst Hub and Massachusetts General Brigham Gene and Cell Therapy Institute (GCTI).
The Investor Catalyst Hub is excited to feature a panel of representatives from investor and venture capital spoke organizations at our May member meeting. With a focus on health innovation and impact investing, we look forward to welcoming the following panelists for an engaging discussion: Erin Sietstra, Head of Investments, Hopelab; Erich Scheller, Director, TechAtlas […]
ARPA-H Program Manager Paul E. Sheehan, Ph.D., will join the Investor Catalyst Hub’s virtual monthly meeting to discuss the various programs in his portfolio.
Spokes are invited to join an exclusive virtual networking session that will feature three breakout rooms.
Learn about the ARPA-H Small Business Program, including how to submit an application, eligibility considerations, and details of current open topics.